Editor(s):
(1) Dr. Takashi Ikeno, National Cancer Center Hospital East, Clinical Research Support Office, Japan.
Reviewers:
(1) Polepalli Mallikarjuna Rao, Dr.NTR UHS, India.
(2) Gunji Venkateswarlu, School of Pharmacy, The Assam Kaziranga University, India.
Additional Reviewers:
(1) A.Nirmala, Aarupadai Veedu Institute of Technology, India.
(2) Enas Abdulsahib Badi, Iraq.
(3) Marbe Alexandra Cardona, Corporación Universitaria Lasallista, Colombia.
(4) A.Nirmala, Aarupadai Veedu Institute of Technology, India.
(5) Polepalli Mallikarjuna Rao, Dr.NTR UHS Vijayawada, India.
Additional Reviewers: (Comments received after deadline)
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer Review Report_1 (Polepalli Mallikarjuna Rao, India) | File 1 | NA
Stage 2 | Peer Review Report_2 (Gunji Venkateswarlu, India) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA